Marshall Wace’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-84,508
| Closed | -$8.62M | – | 2608 |
|
|
2023
Q2 | $8.62M | Sell |
84,508
-330,446
| -80% | -$33.7M | 0.02% | 695 |
|
|
2023
Q1 | $37.7M | Buy |
414,954
+209,612
| +102% | +$19.1M | 0.08% | 244 |
|
|
2022
Q4 | $7.8M | Buy |
205,342
+193,342
| +1,611% | +$7.35M | 0.02% | 823 |
|
|
2022
Q3 | $302K | Buy |
+12,000
| New | +$302K | ﹤0.01% | 2230 |
|
|
2021
Q1 | – | Sell |
-10,516
| Closed | -$1.3M | – | 2652 |
|
|
2020
Q4 | $1.3M | Buy |
10,516
+3,591
| +52% | +$444K | 0.01% | 998 |
|
|
2020
Q3 | $675K | Buy |
+6,925
| New | +$675K | ﹤0.01% | 1118 |
|
|
2018
Q2 | – | Sell |
-10,600
| Closed | -$217K | – | 880 |
|
|
2018
Q1 | $217K | Buy |
+10,600
| New | +$217K | 0.01% | 512 |
|